Submit Deal

Submit Deal

Cover Image ASCEND GENE AND CELL THERAPIES

ASCEND GENE AND CELL THERAPIES

ASCEND GENE AND CELL THERAPIES

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 124 M

Avg. Deal Size£ 62 M

Market Context

Sort

10 Feb 2023|Germany|Biotechnology

Target: FREELINE THERAPEUTICS (GERMAN SUBSIDIARY)

Bidder: ASCEND GENE AND CELL THERAPIES

3 Service Providers

1 Bidder | 2 Vendor

7 Dealmakers

1 Bidder | 6 Vendor

£ 20 M

Value

10 May 2023|United Kingdom|Biotechnology

Target: ASCEND GENE AND CELL THERAPIES

Bidder: CATHAY CAPITAL PRIVATE EQUITY

3 Service Providers

1 Target | 2 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 103 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite